Topics

Will sky-high drug prices spur the US to use an obscure power over patents?

06:08 EST 4 Dec 2019 | BioPharmaDive

New cell therapies as well as gene-based treatments like Zolgensma benefited from NIH funding of early-stage research. Advocates say the time is now for the government to invoke its 'march-in' rights. 

Original Article: Will sky-high drug prices spur the US to use an obscure power over patents?

NEXT ARTICLE

More From BioPortfolio on "Will sky-high drug prices spur the US to use an obscure power over patents?"

Quick Search

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...